Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer

Adjuvant endocrine therapy (AET) prevents recurrence after early stage, hormone sensitive breast cancer; however, adherence to AET is suboptimal, and efficacious interventions are severely lacking. Barriers to adherence are well established; however, interventions, thus, far have failed to produce m...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical psychology in medical settings 2021-09, Vol.28 (3), p.603-618
Main Authors: Jacobs, Jamie M., Walsh, Emily A., Rapoport, Chelsea S., Antoni, Michael H., Park, Elyse R., Post, Kathryn, Comander, Amy, Peppercorn, Jeffrey, Safren, Steven A., Temel, Jennifer S., Greer, Joseph A.
Format: Article
Language:English
Subjects:
Adjuvants
Breast cancer
Cancer therapies
Electronic health records
Endocrine therapy
Estrogens
Family Medicine
Feedback
General Practice
Health Psychology
Intervention
Medicine
Medicine & Public Health
Mortality
Oncology
Patients
Research methodology
Symptom management
Technology Acceptance Model
Telemedicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adjuvant endocrine therapy (AET) prevents recurrence after early stage, hormone sensitive breast cancer; however, adherence to AET is suboptimal, and efficacious interventions are severely lacking. Barriers to adherence are well established; however, interventions, thus, far have failed to produce meaningful changes in adherence and have generally not followed guiding principles of psychosocial intervention development. The purpose of this paper is to describe the iterative development, using the National Institutes of Health Stage Model for Behavioral Intervention Development, of an evidence-based, patient-centered, telehealth intervention to enhance adherence, improve symptom management, and reduce distress for patients taking AET after breast cancer, with a focus on (1) a small open pilot study which informed modifications and refinement of the intervention based on quantitative and qualitative patient feedback about feasibility and acceptability and (2) the underlying theoretical and empirical rationale for each component of the finalized intervention. Clinical implications and directions for future research are discussed.
ISSN:1068-9583
1573-3572
DOI:10.1007/s10880-020-09750-4